Drugs / IgG-RFB4-SMPT-dgA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001271 | Jul 1991 → Apr 2001 | lymphoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IgG-RFB4-SMPT-dgA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001271 ↗ |
| Modality | Protein / enzyme biologic | “immunotoxin” NCT00001271 ↗ |
| Route | Other | “as a 192 hr infusion” NCT00001271 ↗ |